Here are four key points:
1. The company filed the $17 million IPO in September.
2. Without disclosing the reason, SpineEx withdrew its plans for the IPO.
3. Founded in 2017, the Fremont, Calif.-based spine device company received FDA clearance for its lateral lumbar interbody fusion device earlier this year.
4. Prior to its withdrawal, ThinkEquity was the sole bookrunner on the deal, according to the report.
More articles on spine devices:
Medtronic finalizes $1.7B Mazor acquisition: 5 key notes on what to expect next
Stryker, Zimmer Biomet, Smith & Nephew & more: 12 device company notes
Smith & Nephew to acquire Centrix Orthopaedics in $105M deal: 5 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.